Emerge Gaming Limited
Emerge Gaming Limited (ASX:EM1), based in Subiaco, Australia, provides a global online platform which allows users to engage in skill-based gaming competitions in eSports. Currently, the company has a market cap of AUD 19.98 million with ~ 587.59 million outstanding shares. On March 20th, 2019, a trading halt was imposed midday on the securities of Emerge Gaming Limited, awaiting the release of an announcement to the market until March 22nd, 2019. On the same day, EM1âs stock closed at a sell-off price of AUD 0.034, soaring by 13.33%, up AUD 0.004 with ~ 35.72 million shares traded. By the closure of the trading session, the stock of the company stood at A$0.035 as noted on 21 March 2019.
On March 15th, Emerge Gaming released a response to ASXâs price query for the change in stock price from a low of AUD 0.022 to AUD 0.029, accompanied by a rise in its traded shares. Recently, EMI had provided an update to have completed the commercial roll-out strategy as part of the launch of the Arcade X revolutionary Media Gaming Platform in Australia as well as other Tier 1 nations. For the six months to 31 December 2018, the company reported revenue from ordinary activities at $129.61k and the net loss after tax attributable to members at $887.92k.
Galan Lithium Limited
The West Perth-based Galan Lithium Limited (ASX:GLN), is engaged in the acquisition, exploration, and evaluation of mineral projects, with a significant interest in tantalum deposits, tin, lithium, and oil. To date, the companyâs market cap stands at AUD 27.14 million, with ~ 113.1 million outstanding shares. On 21 March 2019, the GLN stock price closed at AUD 0.245, up by 2.083.
On 20 March 2019, Galan released a drilling update for Drillhole C-02-19, identifying fractured basement at 632 meters. The preliminary test indicates conductivity levels of ~ 90k mS/cm and specific gravity of around 1.045, in the final 202 metres to the end of the hole reflecting a major potential for a lithium bearing aquifer. A third drill hole is expected to begin shortly. Besides, the company also announced its half-year results for the six months to December 31st, 2018, posting cash reserves at ~ $ 1.92 million, up on $322.8k in the prior comparable period (PCP). The operating loss after income tax of the Group stood at $ 623.79k, down on $ 631.05k in PCP.
Auscann Group Holdings Ltd
AusCann Group Holdings Ltd (ASX:AC8), headquartered in Joondalup, Australia, is a pharmaceutical company engaged in development, cultivation, production, and sale of clinically verified cannabis medicines to patients domestically and internationally. Currently, AC8 has a market cap of AUD 95.82 million with ~ 309.09 million outstanding shares. The AC8 stock closed at a selling price of AUD 0.315, up by 1.613% from its previous close, as on 21 March 2019.
The company released its investor presentation in March 2019, posting its investment summary, strategy, recent developments and other significant highlights including the financial results. As per the half-year financial report for the six months to December 31st, 2018, the revenue from ordinary activities was up 261% to $466.3k and the net loss for the period attributable to its members amounted to ~ $ 4.44 million, down 8% on PCP.
Disclaimer
This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.